semaglutide vision A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no There is a #credible_link (association)

Preclinical research suggests that GLP1 receptors exist on bone cells such as osteoblasts and osteoclasts

Sandhu JK, Pandey S, Ribecco-Lutkiewicz M, Monette R, Borowy-Borowski H, Walker PR, et al

Rubinger: How much of that would we consider to be genetics and how much would we consider to be lifestyle, leading to the disease itself

Similarly, evidence for oxidative stress markers like MDA is promising but varied, with some trials showing clear superiority of GLP-1 RAs over insulin or metformin (9, 21, 22)

doi:10.1080/19396368.2016.1246623

These compensatory awards require juries or settlement negotiators to assign monetary value to subjective experiences of pain, disability, and diminished quality of life